NIFTY 50
24,946.50 (0.92%)
NIFTY IT
39,073.05 (1.57%)
NIFTY AUTO
23,368.25 (0.18%)
NIFTY FINANCIAL SERVICES
26,554.75 (0.83%)
NIFTY BANK
55,944.90 (0.75%)
NIFTY REALTY
1,020.30 (1.32%)
NIFTY ENERGY
36,010.45 (0.76%)
NIFTY METAL
9,358.25 (1.07%)
NIFTY FMCG
54,873.30 (0.63%)
NIFTY HEALTH CARE
14,396.10 (0.47%)
NIFTY PHARMA
22,039.45 (0.25%)
NIFTY MEDIA
22,039.45 (0.25%)
Platforms
Desktop Application
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Login
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Login
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Lupin Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value
531.61
NSE Symbol
LUPIN
Dividend Yield (%)
0.6
Market Cap (
₹
Cr.)
91,355.08
P/E
22.63
EPS
88.38
Face Value
2
Date
Headline
27-May-25
Lupin allots 78,930 equity shares under ESOP
26-May-25
Lupin enters into license and supply agreement with SteinCares
20-May-25
Lupin to develop next-gen inhalers using Honeywell's Solstice® Air propellant
15-May-25
Board of Lupin recommends final dividend
13-May-25
Lupin launches Tolvaptan Tablets in US market with 180-day exclusivity
30-Apr-25
Lupin announces board meeting date
24-Apr-25
Lupin receives USFDA approval for Tolvaptan Tablets
21-Mar-25
Lupin allots 24,101 equity shares under ESOP
17-Mar-25
Lupin receives USFDA tentative approval for Amifampridine Tablets
07-Mar-25
Lupin launches Rivaroxaban Tablets USP, 2.5 mg in the US
Prev
1
2
3
Next